• New biomarkers may help monitor treatment responses to perioperative immunotherapy for patients with lung cancer
  • Researchers demonstrate that donor cord blood composition could influence outcomes of CAR NK cell therapy
  • Immune cell signaling plays important roles in skin cancer development, arthritis following immunotherapy treatment, and responses to rapid-acting antidepressants
  • The gut microbiome and tumor microenvironments are emerging treatment targets to improve chemotherapy delivery and overcome drug resistance